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INTRODUCTION
S
ystemic lupus erythematosus is an autoimmune dis-
ease characterized by antibodies that bind a wide
range of nuclear and cellular antigens, including
DNA.1 Increased serum anti-DNA autoantibody
(anti-DNA) levels often correlate with disease activ-
ity.2,3 Some anti-DNA localize to the glomerular basement
membrane by binding DNA adherent to the membrane that
results in renal damage.4–7 Given the key role of antigen rec-
ognition, the binding properties of anti-DNA monoclonal
antibodies (mAbs) have been extensively studied.8–12 These
investigations are predicated on the assumption that under-
standing anti-DNA recognition would enable meaningful
predictions of disease severity, provide a means to differenti-
ate pathogenic from nonpathogenic mAbs, and even high-
light strategies for interference to prevent formation of path-
ogenic complexes. Despite considerable effort, a cogent link
between DNA recognition and disease pathogenesis is yet to
be established. Previously, we generated a panel of anti-DNA
from an MRL lupus prone mouse (MRL/lpr) to probe for
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links between binding properties and pathogenesis.13,14 Two
mAbs 9F11 and 15B10 showed preference for oligo thymine,
but only one mAb, 11F8, was sequence-specific.15 Adminis-
tration of 11F8, 9F11, and 15B10 to normal mice revealed
that only 11F8 was pathogenic.13
Somatic hypermutation is a process that occurs in mAb
genes during affinity maturation, where localized mutations
can profoundly affect antigen binding.16,17 Remarkably, the
primary sequence of 11F8, 9F11, and 15B10 differs by five or
less amino acids, and these differences are localized to the
variable region of the heavy chain (VH) (Figure 1). Two bind-
ing site residues, R31VH and
Y100VH, which have been shown
to mediate sequence-specificity in 11F8, were acquired dur-
ing affinity maturation, and they are unmutated in both
9F11 and 15B10.19,20 Since DNA binding properties are in-
herent to primary sequence, 11F8, 9F11, and 15B10 provide
an attractive model system to compare and contrast DNA
binding properties of anti-DNA with distinct biological
properties. In these studies, the binding properties of 9F11
and 15B10 to different DNA sequences: 11F8 high affinity
consensus sequence, (1), oligo thymine (T7), and a nonspe-
cific ssDNA ligand (NS), were determined and compared
with 11F8 (Figure 2).20–22 Two 11F8 reversion mutants,
R31SVH and
Y100FVH, were constructed to mimic residues
present in 9F11 and 15B10. Thermodynamic and kinetic
studies of the reversion mutants supported the hypothesis
that R31VH is primarily responsible for the differences
observed between 11F8, 9F11, and 15B10. Our data support
a model where pathogenic anti-DNA arise at the level of so-
matic mutation during affinity maturation. Somatic muta-
tion to certain amino acids such as arginine or at specific
variable region positions may be a feature that distinguishes
pathogenic anti-DNA from those that are benign.
MATERIALS AND METHODS
Protein Preparations
Intact 11F8, 9F11, and 15B10 were isolated from ascities fluid and
purified by affinity chromatography (> 95%) as previously de-
scribed.14 Antibody concentrations were calculated from the A280
with an extinction coefficient (0.67 mg ml1/OD280) calculated
from the amino acid sequence.23
Determination of the thermodynamic parameters and rate con-
stants for reversion mutants required recombinant expression of the
single-chain 11F8 variable region.20 11F8 was cloned into the pET-
28b(+) vector (Novagen, Madison, WI), and 11F8 reversion mutants
R31SVH (arginine to serine mutation at position 31 of the heavy chain
variable region), Y100FVH, and
R31S,Y100FVH were constructed using
Quickchange Site-Directed Mutagenesis Kit (Stratagene, La Jolla,
CA). The mutant proteins were expressed, purified, and quantified as
described for wild-type 11F8.20 The stability of each mutant was veri-
fied through guanidine unfolding and compared with the wild-type
11F8.20 Proteins were purified to >98% as judged by gel electropho-
resis for thermodynamic and kinetic studies.
Steady-State Fluorescence Affinity Measurements
DNA sequences were synthesized, purified to >95% by HPLC, and
quantified as previously described.15,21 Fluorescence measurements
were carried out on a Spectronic AB2 fluorimeter with magnetic
FIGURE 1 Sequence alignment of the heavy chain variable residues for clonally related mAbs
11F8, 9F11, and 15B10. Sequence differences are localized to the heavy chain. Complementarity
determining regions are colored blue and mutations resulting from somatic hypermutation are
noted in bold. Sequences are numbered according to Kabat et al.18
FIGURE 2 Sequence of ssDNA ligands used in binding studies. 1
is the high affinity sequence for 11F8.15 Nucleotides that functioned
as PCR primers during selection but do not participate in recogni-
tion are not shown (*). In the thymine rich sequence, T7, positions
3, 8–14, and 16 of 1 are replaced with thymine to remove structural
and recognition elements. All bases are represented equally in NS,
which adopts no secondary structure. Ligands used in thermody-
namic studies are 55 nucleotides long. Kinetic studies were com-
pleted with a 19 nucleotide truncated hairpin that removed PCR
primers. Truncation does not decrease binding affinity.22
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stirrer and thermostated cellblock.21 Briefly, antibody was diluted
into titration buffer (20 mM Tris, 150 mM NaCl, pH 8.0) and
allowed to equilibrate at 258C. The quench in intrinsic tryptophan
fluorescence was monitored as a function of added DNA and fit to
the single-site binding isotherm to obtain the dissociation con-
stant.21 Thermodynamic parameters were determined as previously
described.21
Stopped-Flow Measurements
Stopped-flow measurements were conducted using a p*-CDF
stopped-flow spectrophotometer from Applied Photophysics
(Surrey, UK). The apparent association (kon) and dissociation (koff)
rate constants were determined as previously described.22,24 Briefly,
the excitation wavelengths were the same as used for equilibrium
experiments and the emission was monitored with suitable cutoff
filters. All measurements were performed in 20 mM Tris-HCl, pH
8.0, 100 mM NaCl, 20% w/v sucrose at 58C. Because initial signal
changes observed on binding were rapid, occurring within the dead-
time of the instrument, 20% sucrose was added to increase buffer
viscosity, and temperature was lowered to 58C to decrease the rate
of association such that the quench upon binding was observed
completely with respect to initial protein fluorescence. Each experi-
ment was carried out at least eight times and analyzed both individ-
ually and as an average by single or double exponential curve fitting
algorithms using the software supplied with the instrument.
In experiments to determine the association rates for complex
formation, [mAb] prior to mixing (100 nM for whole mAbs con-
taining two antigen binding sites or 200 nM for single-chain 11F8
varaints containing a single binding site) was kept constant while
the DNA was maintained in at least a 10-fold excess to approximate
pseudo-first-order reactions conditions. From the plot of [DNA]
versus kapp, the apparent second-order rate constants, kon, were cal-
culated from the slope, and the dissociation of the complex, koff,
was calculated from the y-intercept. Because of the high affinity of
the complex, dissociation experiments were carried out by mixing a
preformed complex (11F81AP) with 10-fold excess of 1 (1:1 v/v)
as previously reported.22 The fluorescence of amino purine was
monitored as the complex dissociated.
RESULTS
Selection of DNA Sequences for Thermodynamic
and Kinetic Studies
Single-stranded DNA binding properties were determined
for three clonally-related mAbs to evaluate whether differen-
ces in thermodynamic and kinetic parameters for recognition
of ssDNA exist, and to establish if these differences relate to
pathogenicity. Three DNA sequences were chosen for evalua-
tion of binding parameters. 1 is the high affinity consensus
sequence for 11F8 identified in binding site selection experi-
ments.15 Prior studies show that 11F8 binds this ligand
sequence specifically.20 Many ssDNA-binding proteins,
including 11F8, 9F11, and 15B10, display a base preference
for thymine, and affinity for oligo thymine was analyzed for
noncognate binding.14,25–30 T7 was chosen to examine recog-
nition of this homopolymer within the same context as 1. NS
is a nonspecific ligand that represents all bases equally, and
like T7 does not possess secondary structure.
Comparison of Thermodynamic Parameters for
mAb1 Recognition
To determine the enthalpic and entropic driving force for
mAb recognition of different ssDNA ligands, affinity meas-
urements were conducted as a function of temperature. Data
were plotted in van’t Hoff form (ln Kobs vs. 1/T) and ana-
lyzed assuming either zero or constant negative heat capacity
based on either linear or nonlinear dependence of affinity on
temperature, respectively.31–33 The limitations of this analy-
sis are discussed in a recent review, and representative van’t
Hoff plots are included as supplementary information.34
11F8 binds 1 seven-fold tighter than 9F11 and 15B10
(Table I). Lower affinity may reflect either the absence of
specific contacts as compared with the 11F81 complex or a
different mode of binding. Thermodynamic parameters for
recognition of 1 were determined for 9F11 and 15B10 by
measuring binding affinity as a function of temperature (Ta-
ble I). Similar to 11F8, recognition of 1 by 9F11 and 15B10
is enthalpically favorable and opposed by entropy. The ther-
modynamic parameters for 9F111 and 15B101 are within
error of 11F81 values, and uncertainties in enthalpy and
entropy values render them indistinguishable from 11F8.
From thermodynamic parameters alone, it is not possible to
ascribe the source of the weaker affinities of 9F11 and 15B10
for 1 to processes that are either primarily entropic or
enthalpic. The nonclassical hydrophobic effect is the largest
contributor to the favorable enthalpy observed for 11F8 rec-
ognition of 1.21 To determine whether the net enthalpy
changes associated with 9F11 and 15B10 recognition of 1
reflect similar processes, binding affinity was determined as
a function of buffer polarity (glycerol and 1-propanol).
Decrease in solution polarity weakens binding similarly in
all three mAbs, which suggests in all cases, the hydrophobic
effect provides a significant driving force for recognition
(data not shown).
One of the sequence differences between 11F8 and both
9F11 and 15B10 is found at 31VH. 9F11 and 15B10 have a
germline serine while somatic hypermutation in 11F8 affords
arginine.19 Mutagenesis and structural studies suggest that
R31VH at the periphery of the binding site contacts 1 through
both salt bridge and specific base contacts.20,24,35 A binding
site serine in place of arginine means loss of positive charge
at the interface, eliminating potential hydrogen bond and
electrostatic contacts with the DNA backbone. While direct
side chain-base contacts could only be assessed through
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double mutant studies, a change in the number of putative
salt bridge interactions would be evident from the stoichiom-
etry of cation release accompanying complex formation.31
Reduction in salt bridge formation could alter the thermody-
namic impact of the polyelectrolyte effect, which contributes
to binding through a favorable entropy change.
To measure salt release upon complex formation, mAb1
affinity was determined as a function of buffer salt concen-
tration. As shown in Table I, stoichiometries of salt release
for 9F111 and 15B101 suggest only one salt bridge in these
complexes, while 11F81 has two. This change translates a
reduced energetic contribution of the polyelectrolyte effect,
from *22% of the total binding energy for 11F81 to
roughly half that amount in the 9F11 and 15B10 complexes.
Thus, the weaker affinity of 9F11 and 15B10 for 1 could
result exclusively from the entropic impact of salt bridge
reduction in the absence of a binding site arginine.
Comparison of Thermodynamic Parameters for
mAbNS Recognition
The polyelectrolyte effect drives nonspecific recognition of
ssDNA by 11F8.21 Shift in driving force from the nonclassical
hydrophobic effect for sequence-specific recognition of 1 to
the polyelectrolyte effect reflects the ability of 11F8 to adapt
its mode of binding to achieve the most favorable set of con-
tacts with the available DNA ligand. The affinity of 11F8 for
NS DNA is greater than fivefold tighter than the affinity of
9F11 and 15B10 for the same sequence (Table II). Thermody-
namic parameters accompanying 9F11NS and 15B10NS
complex formation suggest that recognition of NS is driven
by favorable enthalpy change and opposed by entropy, and
that these mAbs do not utilize the polyelectrolyte effect to
the same extent as 11F8 (Table II). For 11F8NS, the esti-
mated contribution of cation release is 10.0 kcal mol1,
which is >100% of the observed binding energy. This analysis












11F8 106 1 10.9 6 0.1 22 6 2 116 2 2.2 6 0.1 2.5 6 0.1
9F11 696 17 9.8 6 0.2 23 6 1 136 1 1.0 6 0.1 1.1 6 0.1
15B10 726 8 9.8 6 0.1 24 6 2 146 2 1.3 6 0.1 1.4 6 0.1
11F8 data are included for reference. 11F8 thermodynamic parameters were estimated by assuming a constant negative heat capacity due
to curvature in the van’t Hoff plot.21 Errors for Kd and DG are the standard deviations of at least three independent assays. Errors reported for
DH, TDS, SKobs, and DGelect reflect either uncertainty associated with nonlinear least-squares regression or the standard deviation of the
slope of the linear van’t Hoff plot as previously described.21
a Affinity data were measured in 20 mM Tris, 150 mM NaCl, pH 8.0 at 258C.
b The change in affinity with respect to temperature measured from 5 to 358C was used to determine thermodynamic parameters for 9F11
and 15B10 assuming a zero heat capacity change due to linearity of the van’t Hoff plot (lnKd vs. 1/T).
c Values of SKobs represent the stoichiometry of salt release determined at 258C with buffer salt concentrations ranging from 85–300 mM
as described by Record.31
d The energetic contribution of salt release (DGelect) at 150 mM NaCl was calculated as described by Record.
32












11F8 0.4 6 0.1 8.86 0.1 0 8.8 6 0.1 7.3 6 0.1 10.0 6 0.1
9F11 2.2 6 0.4 7.76 1.1 11.6 6 0.5 3.9 6 0.9 3.2 6 0.1 4.3 6 0.1
15B10 5.0 6 1.0 7.26 0.8 15.0 6 13 8.0 6 7.0 3.2 6 0.1 4.4 6 0.1
Refer to Table I for footnote definitions except for the following modifications. 11F8 data are included for reference. 11F8 thermodynamic
parameters were estimated by assuming a zero heat capacity change due to linearity of the van’t Hoff plot.21
a Affinity data were measured in 20 mM Tris, 100 mM NaCl, pH 8.0 at 258C.
b Thermodynamic parameters for 9F11 and 15B10 were determined assuming a constant negative heat capacity suggested by curvature in
the van’t Hoff plot (lnKd vs. 1/T).
c The stochiometry of salt release was determined with buffer salt concentrations ranging from 85–150 mM.
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suggests that the polyelectrolyte effect may be the sole driving
force for nonspecific ssDNA recognition by 11F8, while the
polyelectrolyte effect contributes only *60% of the total free
energy for the 9F11NS and 15B10NS complexes.
Previous studies have suggested that pathogenic anti-
DNA may be more basic in nature than nonpathogenic
mAbs since the isoelectric points (pI) for mAbs isolated form
kidney tissue are more basic than serum antibodies, ranging
between 7.2 and 9.2.36 The pIs for the variable regions of
11F8, 9F11, and 15B10 are basic at 8.9, 8.9, and 8.7, respec-
tively; however, 9F11 and 15B10 are not pathogenic. Seq-
uence comparison for variable regions reveal identical light
chains, and heavy chains containing a similar number of
charged side chains (13 positive and 9 negative side chains in
11F8 and 9F11, and 12 positive and 9 negative side chains in
15B10). Thus, differences in affinity and mode of binding
likely result from the absence of a specific cationic arginine at
the DNA binding site of 9F11 and 15B10 rather than
sequence differences in the variable region.37
Comparison of Thermodynamic Parameters for
mAbT7 Recognition
9F11 and 15B10 bind T7 with higher affinity than 11F8
(Table III). Since these mAbs bind NS with lower affinity
than 11F8, higher affinity for T7 reflects increased preference
for thymine-rich sequences rather than simply increased af-
finity for DNA. The thermodynamic parameters accompany-
ing 9F11 and 15B10 recognition of T7 were determined to
identify the driving force for thymine base preference. As for
11F8, recognition of T7 by 9F11 and 15B10 is driven by a
favorable enthalpy change and opposed by entropy. Both en-
thalpy and entropy changes for 9F11 and 15B10 recognition
of T7 are smaller than for 11F8 indicating that complex for-
mation is less enthalpically favored and less entropically dis-
favored. These data suggest that the higher affinities of 9F11
and 15B10 for T7 could be a consequence of smaller entropic
costs associated with binding. Increases in salt release for
9F11T7 and 15B10T7 complexes could contribute to the
smaller unfavorable entropy change observed. However, salt
release stoichiometries are smaller than those observed for
11F8, as are the thermodynamic contributions of the polye-
lectrolyte effect (Table III). Hence, an increased salt release is
not the source of the more favorable entropy change
observed for 9F11T7 and 15B10T7.
Increased affinity of 9F11 and 15B10 for T7 relative to
11F8 could also result from increased involvement of the
hydrophobic effect; however, the sensitivity of 9F11 and
15B10 affinity for T7 was affected by bulk solution polarity
to the same extent as 11F8T7 suggesting similar involve-
ment of the hydrophobic effect (data not shown).21 Pro-
teinDNA interactions depend strongly on the contacts avail-
able, and a single protein may bind two different DNA
sequences in different modes, with different interface
contacts.38 Nonspecific recognition of DNA is typically
dominated by electrostatic interactions showing stronger salt
concentration dependence than corresponding specific bind-
ing.33,39,40 When 11F8 binds NS, the recognition mode shifts
from enthalpically driven to entropically driven and the elec-
trostatic component of the binding energy increases from
*20% in sequence-specific binding to 100% in nonspecific
binding. However, both 9F11 and 15B10 recognition of NS
remains enthalpically favorable, suggesting that electrostatic
contacts play far less a role in DNA binding. We hypothesize
that 9F11 and 15B10 have an inherent propensity to accom-
modate two thymine nucleotides. Because thymine nucleo-
tides could bind nondiscriminatorily in many different regis-
ters along the ssDNA ligand, such accommodation could
explain the high affinity for T7.
Kinetics of mAb Binding to 1
To probe if differences in the kinetics of DNA recognition
exist for 11F8, 9F11, and 15B10, association and dissociation












11F8 1400 6 200 8.0 6 0.1 28.7 6 0.6 20.7 6 0.6 3.4 6 0.1 1.6 6 0.1
9F11 160 6 30 10.1 6 0.1 25.8 6 0.9 15.7 6 0.9 2.3 6 0.2 1.1 6 0.2
15B10 426 4 9.3 6 0.1 24.2 6 0.8 14.9 6 0.8 2.1 6 0.1 1.0 6 0.1
Refer to Table I for footnote definitions except for the following modifications. 11F8 data are included for reference. 11F8 thermodynamic
parameters were estimated by assuming a zero heat capacity change due to linearity of the van’t Hoff plot.21
a Affinity data were measured in 20 mM Tris, 450 mM NaCl, pH 8.0 at 258C.
b The stochiometry of salt release was determined with buffer salt concentrations ranging from 100–450 mM.
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rate constants were measured for each antibody with 1 and
T7. The kinetic parameters for recognition of NS were not
completed because affinity differences were sufficiently
explained by thermodynamic parameters alone. DNA bind-
ing is accompanied by a 40% quench in tryptophan fluores-
cence for all three mAbs. Exponential fit of the decrease in
tryptophan fluorescence was used to determine kinetic rate
constants for recognition of ssDNA.22,24 11F81 complex for-
mation occurs in two steps as evidenced by a double expo-
nential decay in tryptophan fluorescence. An initial encoun-
ter complex is formed, followed by a slower rate-limiting
conformational change that results in the high affinity com-
plex.22 Unlike 11F8, a single exponential curve fits the
decrease in fluorescence observed for 9F11 and 15B10 recog-
nition of 1 (Figure 3A). For 9F11 and 15B10, the single
observed rate is slow and independent of [1] similar to the
second step in 11F81 association (Table IV).
We expected that the rate of encounter complex formation
would decrease with one less arginine at the binding site of
9F11 and 15B10 since association is directly related to the
magnitude of electrostatic forces between two interacting
surfaces.41,42 However, the observation of a single rate that is
independent of [DNA] suggests that formation of a bimolec-
ular encounter complex does not cause a disemable fluores-
cence quench under these experimental conditions. A single
observed association rate for both 9F111 and 15B101
binding is consistent with rate constants for an 11F8 mutant
in which four arginine side chains were removed from the
FIGURE 3 Representative stopped-flow fluorescence traces for the interaction between 11F8 and
ssDNA in 20 mM Tris, 100 mM NaCl, pH 8.0, 20% w/v sucrose at 58C. A: Double exponential asso-
ciation traces for the interaction between 1 (2 lM) and 11F8 (100 nM) and single exponential traces
for the interaction between 1 and 9F11 and 15B10. Buffer viscosity was increased and temperature
was decreased such that the binding event did not occur within the dead time of the instrument.
B: Double exponential association traces for the interaction between T7 (2 lM) and mAbs
(100 nM). Fluorescence traces are artificially scaled so that spectra do not overlap.
Table IV Kinetic Parameters for mAb Recognition of ssDNA Ligands 1 and T7
Complex k1 (lM





11F81 9.3 6 0.6 3.9 6 0.4 4.5 6 0.2 2.5 3 103 6 23 105 0.3 6 0.2
9F111 NO NO 2.4 6 0.4 3.6 3 103 6 53 106 2.7 6 0.2
15B101 NO NO 1.7 6 0.3 4.2 3 103 6 43 105 2.8 6 0.4
11F8T7 102.56 7.2 35.2 6 2.6 4.7 6 0.3 3.5 3 103 6 13 103 4.2 6 0.3
9F11T7 35.46 2.6 46.9 6 4.3 11.8 6 0.8 6.7 3 103 6 13 105 0.6 6 0.2
15B10T7 44.66 5.3 33.5 6 4.2 6.7 6 0.2 7.6 3 103 6 13 106 0.9 6 0.3
Rate constants were measured in 20 mM Tris, 100 mM NaCl, pH 8.0, 20% w/v sucrose at 58C. There is one observed step for 9F11 and
15B10 association with 1, NO refers to not observed. Since the observed rate is independent of [1] it is related to final complex (k2) in 11F81
association, which is also independent of [1]. 11F8 data are reported for comparison.22 Errors are the standard deviations of at least eight in-
dependent measurements.
a Reported Equilibrium Kd values were determined in 20 mM Tris, 150 mM NaCl, pH 8.0 at 258C. Errors are the standard deviations of
three independent assays.
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periphery of the DNA binding site. This mutant exhibited
both decrease in equilibrium affinity for 1 and a single expo-
nential fluorescence change upon binding.24 In addition to
changes in the mechanism of association, both the rate of
formation of the final complex, reflected by k2, and its disso-
ciation (k2) are altered in 9F11 and 15B10 binding to 1 as
compared with 11F8. Possessing serine at 31VH, 9F11 and
15B10 DNA binding sites are less positive before somatic
mutation, which decreases the strength of electrostatic attrac-
tion between protein and DNA.
Kinetics of mAbT7 Recognition
Like 11F8, the decrease in fluorescence observed upon the
interaction of 9F11 and 15B10 with T7 fits a double expo-
nential, and binding occurs in two steps (Figure 3B). These
data suggest that recognition of T7 occurs through a similar
mechanism as 11F81, where induced-fit formation of the
final complex is rate-limited by a slow conformational
change described by k2. Both association and dissociation
rates describing 9F11 and 15B10 recognition of T7 differ as
compared with 11F8, and these differences, particularly in k2,
may help to explain the differences observed in affinity at
equilibrium. The effects of the individual association and dis-
sociation rate differences with respect to 11F8 for all but k2
(decreased rate of association to form the encounter com-
plex, k1, increased rate for dissociation of the encounter
complex, k1, and increased rate for dissociation of the final
complex, k2) would have a net decrease on equilibrium af-
finity. However, we observe increased affinity between 9F11
and 15B10 for T7, which could result from the increased rate
of formation of the high affinity complex (k2) possibly
because of decreases in the activation energy for the rate-lim-
iting second step (Table IV).
Reversion Mutation of 11F8 to Germline
The sequence of 11F8 differs in the same way from both
9F11 and 15B10 at only two positions, 31VH and
100VH. Pre-
vious studies have determined that R31VH and
Y100VH medi-
ate sequence-specificity in the 11F81 complex.20 Based on
thermodynamic, kinetic, and structural studies, we hypothe-
size that R31VH and
Y100VH contribute to sequence-specific
binding through base-specific hydrogen bonds, electrostatic
interactions, and base stacking.20,21,35 These contacts are ac-
cessible to arginine and tyrosine side chains and have been
observed in a range of proteinnucleic acid systems.43–47 The
effects of amino acid changes acquired through somatic
mutation, on thermodynamic and kinetic parameters for
DNA binding, were evaluated with reversion mutants. Unlike
the other experiments completed with whole mAbs, recombi-
nant single-chain 11F8 was used for all reversion mutant
studies. We have previously shown that the affinity, specific-
ity, thermodynamics, and kinetics of binding by single-chain
11F8 are consistent with 11F8.20,22 R31VH and
Y100VH in 11F8
were selected for reversion mutation to mimic S31VH and
F100VH of 9F11 and 15B10. The serine (
R31SVH) and phenylal-
anine (Y100FVH) mutants as well as the double mutant
(R31SY100FVH) were constructed via site-directed mutagenesis
of single-chain11F8.
Analysis of the thermodynamic and kinetic parameters for
the reversion mutants is predicated on the assumption that
sequence differences between these antibodies are localized
to the mutated residue.48 However, changes in DNA binding
properties could also result from a loss of intramolecular
interactions with adjacent protein residues, rather than from
loss of interactions with ligand.49 Such intramolecular inter-
actions can be detected by studying the double mutant to
determine if the effects of the two mutations are additive
(noncooperative) or not (suggest intramolecular interac-
tions).50–53 Double mutant cycles for mutations to R31VH
and Y100VH, among other 11F8 binding site residues, reveal
that very little cooperativity exists between residues of 11F8
and suggest that interactions between residues in the comple-
mentarity determining region (CDRs) do not significantly
contribute to binding.20
The affinity of Y100FVH for 1 is higher than that of 11F8
(Table V). The likely source of higher affinity in the
Y100FVH1 complex is a large decrease in unfavorable entropy
change during recognition. Since affinity increases in the ab-
sence of the tyrosine hydroxyl group, we conclude that while
an energetically stabilizing hydrogen bond may form between
the Y100VH hydroxyl and DNA, this interaction does not pro-
vide a significant driving force for 11F81 binding. Larger
changes in affinity are observed in the R31SVH1 reversion
mutant complex. R31SVH1 recognition occurs with a more
favorable enthalpy change and a less favorable entropy
change than 11F81, which collectively results in lower affin-
ity. Thermodynamic data suggest that absence of arginine at
31VH affects the mode of recognition by altering both
entropic and enthalpic interactions at the binding site. Simi-
lar to the thermodynamic parameters for whole mAbs 9F11
and 15B10, the 11F8 double mutant has *6-fold lower affin-
ity for 1. Because of uncertainty in the measured enthalpy
and entropy it is not possible to ascribe the source of the
weaker affinities to processes that are either primarily
entropic or enthalpic. Somatic mutation to arginine, S31RVH,
seems to be a structural switch whereby 11F8 can take
advantage of different binding site contacts to recognize
ssDNA differently than other mAbs originating from the
same B-cell.
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Rate constants for Y100FVH binding to 1 reveal that the
effect of tyrosine to phenylalanine mutation is small (Table
VI). Y100FVH had little impact on the independent rate con-
stants having values within error of 11F81. Previous studies
showed the nonconservative mutation Y100AVH abrogated
sequence specificity while Y100FVH retained sequence specific-
ity.20 The aromatic moiety at position 100VH likely contrib-
utes to the favorable binding energy in the same way and to
the same extent in all three mAbs.
If the differences in individual rate constants are not due
to Y100FVH, they likely result from
R31SVH. Previous studies
showed that any change to R31VH in 11F8 abrogated sequence
specificity.20 The kinetic parameters for R31SVH and the dou-
ble mutant resembled 9F11 and 15B10 binding to 1 rather
than 11F8. Each of the mutants exhibited a single exponen-
tial decrease in fluorescence upon binding that was slow and
independent of [1]. The lack of an observed encounter com-
plex coupled with a slow rate of formation and fast dissocia-
tion of the final complex was consistent with our expecta-
tions that side chain interactions between R31VH and 1 are
sufficient to control the mechanism of sequence-specific
binding by 11F8.
There could be two explanations for the single observed
quench in tryptophan fluorescence that are consistent with
our experimental observations. First, in the absence of cati-
onic residues at the binding site, the rate of formation of the
bimolecular encounter complex could slow such that it is
indistinguishable from the rate of formation of the high af-
finity complex. Second, an encounter complex forms with a
rate different from the rate of formation of the high affinity
complex, but it cannot be detected by these methods. We
have found that removing cationic character at the binding
site through single conservative mutations that do not abro-




even removal of one of the two salt bridges (R98KVH) results
in slower, albeight detectable, association to form the en-
counter complex.24 It was surprising that mutagenesis of a
single binding site charged residue at 31VH rendered k1 unde-
tectable because experimental conditions were tailored to
capture the extremely fast encounter complex formation (k1)
during 11F81 association.24 It stands to reason that a slower
association rate to form the encounter complex should be
detectable.
Previous mutagenesis studies showed that a single
decrease in fluorescence independent of [DNA] was also
observed for the W33FVH mutant in which minimal difference
in binding affinity was observed with respect to wild-type
11F81 (0.45 6 0.1 nM and 0.31 6 0.1 nM, respectively).24 It
is possible that the signal change associated with k1 originates
from W33VH. This residue lies within the DNA binding











11F8 9.5 6 0.6 11.0 6 0.4 17.1 6 2.0 6.3 6 1.0 2.3 6 0.2 2.6 6 0.2
Y100FVH 5.3 6 0.3 11.4 6 0.2 12.0 6 2.0 0.6 6 0.1 1.3 6 0.1 1.4 6 0.1
R31SVH 286.2 6 11 8.9 6 0.4 26.3 6 0.6 17.4 6 0.4 1.4 6 0.1 1.6 6 0.1
R31SY100FVH 61.8 6 1.4 9.9 6 0.8 15.6 6 0.6 5.8 6 0.2 1.7 6 0.1 1.9 6 0.1
These data were acquired using recombinant single-chain 11F8. Refer to Table I for footnote definitions except for the following modifications.
b Thermodynamic parameters for R31S11F8 and R31SY100F11F8 were determined assuming a zero heat capacity change due to linearity of
the van’t Hoff plot and thermodynamic parameters for Y100F11F8 were determined assuming a constant negative heat capacity suggested by
curvature in the van’t Hoff plot.
c The stochiometry of salt release was determined with buffer salt concentrations ranging from 85–300 mM.
Table VI Kinetic Parameters for 11F8 Reversion Mutant Recognition of 1
Protein k1 (lM




11F8 5.9 6 0.6 13.5 6 1.4 6.4 6 0.3 7.5 3 104 6 6 3 105 0.3 6 0.1
Y100FVH 5.9 6 0.5 13.3 6 1.1 5.6 6 0.6 8.5 3 10
4 6 1 3 105 0.3 6 0.1
R31SVH NO NO 1.4 6 0.2 4.5 3 10
3 6 2 3 104 5.2 6 1.5
R31SY100FVH NO NO 1.2 6 0.2 1.5 3 10
3 6 9 3 104 6.3 6 1.3
Refer to Table IV for footnote definitions and description of independent rates upon DNA concentration.
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pocket and would be susceptible to small changes in its envi-
ronment as the DNA approaches the binding site. Modeling
studies suggest that W33VH forms more extensive stacking
interactions with T101 in the 11F81 complex than in the cor-
responding R31S11F81 complex where W33VH is minimally
involved in stacking.35 Modeling data support the lack of an
observed encounter complex for R31VH mutants by suggest-
ing that sufficient conformational change to cause a fluores-
cent response may not occur at W33VH when the encounter
complex forms.
DISCUSSION
Cationic residues, such as arginine attract, orient, and stabi-
lize oppositely charged ligands within protein-binding
sites. Proteinprotein,54,55 proteinsmall molecule,56 pro-
teinnucleic acid,57–59 and enzymesubstrate60 complexes all
demonstrate that arginine residues at the binding site are
involved in ligand recognition through electrostatic interac-
tions and the propensity to form both salt bridge and biden-
tate hydrogen bonds. Basic side chains, arginine in particular,
mediate association rates for mAbantigen complexes, such
as Y0101VEGF, where affinity was enhanced 4-fold through
kon by incorporating an arginine residue at the periphery of
the binding site with mutagenesis.61
Recent studies suggest an accumulation of arginine, lysine,
and asparagine residues in CDRs of high affinity anti-DNA
antibodies arise from somatic mutation of germline sequen-
ces.62,63 For example, a single somatic mutation to arginine
in LCDR1 (first CDR in the light chain) of mAb B3 alters
DNA and histone binding properties, and may mediate path-
ogenicity in SCID mice.62 Because of their involvement in
antigen binding, heavy chain sequences, particularly HCDR1
and HCDR2, are most extensively mutated to improve DNA
binding.64,65 HCDR2 of anti-dsDNA antibody 3H9 contains
three somatic mutations, one being to arginine at position
53VH. Reversion of arginine to the germline glycine abolished
dsDNA binding while reversion of the other two somatic
mutations had no effect on DNA binding.66 These data sug-
gest that both the nature and location of binding site muta-
tion affect binding affinity. While 31VH is generally not prone
to mutation in many mAbs, anti-DNA isolated from both
human and mouse suggest that somatic mutation at 31VH is
common and often contributes to DNA binding.11,67,68 How-
ever, in the three crystal structures of anti-DNA/RNA bearing
high sequence resemblance and residue usage to 11F8 (DNA-
1, BV04-01, and Jel 103), no contacts between 31VH and
nucleic acid residues were observed.30 Our data suggest that
a mutation acquired during affinity maturation results in
faster association, that together with specific salt bridge and
hydrogen bond contacts, orient and stabilize an ensuing
11F8DNA complex.24,35
Not all lupus anti-DNA are pathogenic, and it is not clear
if a correlation exists between pathogenicity and either affin-
ity or recognition of a particular DNA antigen. 11F8 initiates
kidney inflammation in vivo by binding to ssDNA adherant
to the glomerular basement membrane in kidney tissue.13
Nonpathogenic mAbs 9F11 and 15B10, which differ at 31VH
and 100VH, dissociate from both 1 and T7 faster than 11F8,
despite higher affinities for T7. 11F8 has markedly slower dis-
sociation rates than the other mAbs for both sequence-spe-
cific and nonspecific complexes. These data suggest that
pathogenicity may be related to the stability of the final com-
plex. Once formed these slower-dissociating 11F8DNA
complexes could remain bound to glomerular DNA antigens
longer than nonpathogenic anti-DNA, permitting a more
potent initiation of an inflammatory response.
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